Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_assertion type Assertion NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_head.
- NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_assertion description "[Using a diabody derived from a monoclonal antibody (12G4) directed against the human anti-M�llerian hormone receptor, a biomarker of ovarian cancers for which therapeutic antibodies are already undergoing clinical trials, we describe here a new diabody refolding protocol with various reducing conditions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_provenance.
- NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_assertion evidence source_evidence_literature NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_provenance.
- NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_assertion SIO_000772 22910001 NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_provenance.
- NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_assertion wasDerivedFrom befree-2016 NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_provenance.
- NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_assertion wasGeneratedBy ECO_0000203 NP1006883.RA9cEEyReTmO54Kfziu_C-A3wF5BmMTdGSODZwyL694hk130_provenance.